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Aim: Patients with peripheral artery disease (PAD) are at very high risk of cardiovascular events.1-3 The 
first Croatian Prospective Peripheral Artery Disease Registry (CRO-PAD) was created in 2010, with the 
aim to collect, organize and present data about patients with PAD. The purpose was to evaluate risk 
factors, prognosticators, longitudinal outcomes, and therapeutic development in order to improve pa-
tients’ healthcare and disease outcomes. 
Patients and Methods: The occurrence of major adverse car-
diovascular events (MACE), defined as composite endpoint of 
acute myocardial infarction, stroke, and death was assessed 
in 1084 symptomatic PAD patients admitted to the University 
Hospital between January 2010 and January 2020 (65% men, 
age 70±10 years). Multivariate Cox regression analysis adjust-
ed for age, gender, traditional cardiovascular risk factors, poly-
vascular disease, chronic limb threatening ischemia (CLTI), 
atrial fibrillation (AF), anemia, statin treatment, and impaired 
renal function was applied to assess the independent predic-
tors of MACE. 
Results: During median follow-up period of 44 months (inter-
quartile range, 23-59 months), 370 patients (34%) experienced 
MACE. Compared to patients without MACE, these patients 
were older, more likely to have diabetes, hypertension, CLTI, 
polyvascular disease, AF, anemia, and renal impairment. In 
multivariate regression analysis, age (HR 1.03, 95% CI 1.02-
1.04), polyvascular disease (HR 1.42, 95% CI 1.15-1.77), CLTI (HR 
1.91, 95% CI 1.54-2.36), AF (HR 1.54, 95% CI 1.18-2.01) and anemia 
(HR 1.65, 95% CI 1.31-2.06) remained independent predictors of 
MACE. Patients with both polyvascular involvement and CLTI 
were four times more likely to experience MACE compared to 
those with PAD alone (Figure 1). 
Conclusion: Polyvascular involvement, critical limb ischemia, 
anemia, and AF were independent predictors of MACE in 
symptomatic PAD patients during long-term follow-up. 
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Figure 1. Cumulative major adverse cardiovascular events 
(MACe) free survival in 1084 symptomatic PAD patients according 
to polyvascular involvement (POLYVASC) and chronic limb threa-
tening ischemia (CLTi).
